Composition of regulatory capital and the TLAC
CCA: Main features of regulatory capital instruments and of other TLAC-eligible instruments
Amounts in millions Swiss francs | ISIN | Par values 31.12.2025 | ||
Common Equity Tier 1 (CET1) | ||||
Share capital | CH125 293 0610 | 183.5 | ||
Additional Tier 1 (AT1) | ||||
Subordinated Additional Tier 1 bond | CH047 507 0238 | 250.0 | ||
Subordinated Additional Tier 1 bond | CH048 526 1355 | 360.0 | ||
Subordinated Additional Tier 1 bond | CH059 785 7785 | 200.0 | ||
Subordinated Additional Tier 1 bond | CH140 547 2155 | 150.0 | ||
Tier 2 capital (T2) | ||||
Subordinated Tier 2 bond | CH111 224 6744 | 400.0 | ||
Subordinated Tier 2 bond | CH145 239 6513 | 200.0 |
The table ‘CCA: Main features of regulatory capital instruments and of other TLAC-eligible instruments is disclosed separately at lukb.ch/aktie-kapitalmarkt under ‘Capital instruments’.
CC1: Composition of regulatory capital
a | b | |||||
|---|---|---|---|---|---|---|
Amounts in millions Swiss francs | 31.12.2025 | References1) | ||||
Common equity (CET1) | ||||||
1 | Issued and paid-in capital, fully eligible | 183.5 | B | |||
2 | Retained earnings reserves, including reserves for general banking risks / profit (loss) carry forwards and profit (loss) for the period | 3,425.0 | C | |||
3 | Capital reserves and foreign currency translation reserve (+/-) and other reserves | 487.1 | D | |||
6 | Common Equity Tier 1 capital before regulatory adjustments | 4,095.5 | ||||
CET1: regulatory adjustments | ||||||
16 | Net long position in own CET1 instruments | – 4.5 | E | |||
28 | Total regulatory adjustments to CET1 | – 4.5 | ||||
29 | Common Equity Tier 1 capital (net CET1) | 4,090.9 | ||||
Additional Tier 1 capital (AT1) | ||||||
30 | Issued and paid in instruments, fully eligible | 960.0 | A | |||
32 | of which classified as liabilities under applicable accounting standards | 960.0 | ||||
36 | Additional Tier 1 capital before regulatory adjustments | 960.0 | ||||
Additional Tier 1 capital: regulatory adjustments | ||||||
37 | Net long position in own AT1 instruments | – 0.3 | ||||
43 | Total regulatory adjustments to AT1 | – 0.3 | ||||
44 | Additional Tier 1 capital (net AT1) | 959.7 | ||||
45 | Tier 1 capital (net Tier 1 = net CET1 + net AT1) | 5,050.6 | ||||
Tier 2 capital (T2) | ||||||
46 | Issued and paid in instruments, fully eligible | 600.0 | A | |||
50 | Valuation adjustments; provisions and depreciation for prudential reasons | 89.5 | ||||
51 | Tier 2 capital before regulatory adjustments | 689.5 | ||||
Tier 2 capital: regulatory adjustments | ||||||
57 | Total regulatory adjustments to T2 | 0.0 | ||||
58 | Tier 2 capital (net T2) | 689.5 | ||||
59 | Regulatory capital (net T1 + net T2) | 5,740.2 | ||||
60 | Total risk-weighted assets | 27,904.3 | ||||
Amounts in % of risk-weighted assets | 31.12.2025 | References1) | ||||
Capital ratios | ||||||
61 | CET1 ratio (item 29) | 14.66 % | ||||
62 | T1 ratio (item 45) | 18.10 % | ||||
63 | Regulatory capital ratio (item 59) | 20.57 % | ||||
64 | Institute specific CET1 buffer requirements in accordance with the Basel minimum standards (capital buffer + countercyclical buffer according to Art. 44a CAO) | 2.50 % | ||||
65 | of which capital buffer in accordance with Basel minimum standards | 2.50 % | ||||
66 | of which countercyclical buffer in accordance with the Basel minimum standards (Art. 44a CAO) | 0.00 % | ||||
68 | CET1 available after meeting the bank's minimum capital requirements | 10.16 % | ||||
68a | CET1 total requirement target in accordance with Annex 8 of the CAO plus the countercyclical buffers according to Art. 44 and Art. 44a CAO | 9.01 % | ||||
68b | of which countercyclical buffers according to Art. 44 and Art. 44a CAO | 1.21 % | ||||
68c | CET1 available | 14.66 % | ||||
68d | T1 total requirement in accordance with Annex 8 CAO plus the countercyclical buffers according to Art. 44 and Art. 44a CAO | 10.81 % | ||||
68e | T1 available | 18.10 % | ||||
68f | Total requirement for regulatory capital as per Annex 8 CAO plus the countercyclical buffers according to Art. 44 and Art. 44a CAO | 13.21 % | ||||
68g | Regulatory capital available (total capital ratio) | 20.57 % | ||||
Amounts in millions Swiss francs | 31.12.2025 | References1) | ||||
Amounts below the thresholds for deduction (before risk-weighting)2) | ||||||
72 | Non-qualified participations in the financial sector | 24.7 | ||||
73 | Other qualified participations in the financial sector (CET1) | 4.1 | ||||
Applicable caps on the inclusion of items in T2 | ||||||
76 | Valuation adjustments eligible in T2 in the context of the SA-BIS approach | 89.5 | ||||
77 | Cap on inclusion of valuation adjustments in T2 in the context of the SA-BIS approach | 306.8 |
1)The references relate to Section ‘CC2: Reconciliation of regulatory capital to the balance sheet‘. References A and B are described in Section ‘CCA: Main features of regulatory capital instruments and of other TLAC-eligible instruments‘.
2)Amounts below the threshold are subject to the normal capital requirement.
CC2: Reconciliation of regulatory capital to the balance sheet
a | b | c | ||||
Amounts in millions Swiss francs | 31.12.2025 | 31.12.2024 | References1) | |||
Assets | ||||||
Liquid assets | 7,797.9 | 8,212.6 | ||||
Amounts due from banks | 658.6 | 346.2 | ||||
Amounts due from securities financing transactions | 0.0 | 0.0 | ||||
Amounts due from clients | 5,434.9 | 5,138.6 | ||||
Mortgage loans | 40,917.7 | 38,235.4 | ||||
Trading activities | 1,692.9 | 1,489.2 | ||||
Positive replacement values of derivative financial instruments | 89.6 | 174.4 | ||||
Financial investments | 5,290.1 | 5,153.7 | ||||
Accrued income and prepaid expenses | 100.7 | 101.0 | ||||
Non-consolidated participations | 28.3 | 29.0 | ||||
Tangible fixed assets | 213.8 | 218.5 | ||||
Other assets | 24.6 | 55.4 | ||||
Capital not paid in | 0.0 | 0.0 | ||||
Total assets | 62,249.1 | 59,154.1 | ||||
Liabilities | ||||||
Amounts due to banks | 5,706.2 | 4,102.4 | ||||
Amounts due to securities financing transactions | 2,571.9 | 3,861.8 | ||||
Amounts due in respect of customer deposits | 30,009.6 | 29,101.6 | ||||
Trading portfolio liabilities | 55.9 | 88.2 | ||||
Negative replacement values of derivative financial instruments | 176.6 | 480.9 | ||||
Liabilities from other financial instruments at fair value | 927.7 | 695.2 | ||||
Medium-term notes | 206.2 | 282.5 | ||||
Bonds and mortgage-backed bonds | 18,053.0 | 16,417.1 | ||||
Accrued expenses and deferred income | 273.2 | 287.0 | ||||
Other liabilities | 17.2 | 52.3 | ||||
Provisions | 26.8 | 30.4 | ||||
Total liabilities | 58,024.5 | 55,399.3 | ||||
of which subordinated liabilities eligible as Tier 2 capital (T2) | 600.0 | 400.0 | A | |||
of which subordinated liabilities eligible as Additional Tier 1 capital (AT1) | 960.0 | 810.0 | A | |||
Equity | ||||||
Reserves for general banking risks | 694.4 | 694.4 | C | |||
Share capital | 183.5 | 183.5 | ||||
of which eligible as CET1 | 183.5 | 183.5 | B | |||
of which eligible as AT1 | 0.0 | 0.0 | ||||
3,351.4 | 3,186.0 | C, D | ||||
Own shares | – 4.5 | – 18.5 | E | |||
Total equity | 4,224.6 | 4,045.3 |
1)The references relate to Section ‘CC1: Presentation of regulatory capital‘.
The regulatory scope of consolidation for the calculation of capital adequacy is identical to the scope of consolidation for the preparation of the consolidated financial statements (see the ‘Disclosures on significant shareholdings’ table in Section 8.6 ‘Shareholdings’ of the consolidated notes to the 2025 Annual Report). All significant shareholdings that are not consolidated are risk-weighted. The relevant threshold values are explained in the ‘CC1: Composition of regulatory capital’ section.